TFRC, associated with hypoxia and immune, is a prognostic factor and potential therapeutic target for bladder cancer

ConclusionA combined hypoxia and immune-related gene could be a novel predictive model for OS and immunotherapy estimation of BLCA patients and TFRC could be used as a potential therapeutic target in the future.
Source: European Journal of Medical Research - Category: Research Source Type: research